APA (7th ed.) Citation

C, A., KA, W., V, F., N, L., LC, C., DA, N., . . . JN, K. (2024). Optimization of anti-CD19 CAR T cell production for treatment of patients with chronic lymphocytic leukemia. Molecular therapy. Methods & clinical development, 32(1), 101212. https://doi.org/10.1016/j.omtm.2024.101212

Chicago Style (17th ed.) Citation

C, Amatya, Weissler KA, Fellowes V, Lam N, Cutmore LC, Natrakul DA, Highfill SL, and Kochenderfer JN. "Optimization of Anti-CD19 CAR T cell Production for Treatment of Patients with Chronic Lymphocytic Leukemia." Molecular Therapy. Methods & Clinical Development 32, no. 1 (2024): 101212. https://doi.org/10.1016/j.omtm.2024.101212.

MLA (9th ed.) Citation

C, Amatya, et al. "Optimization of Anti-CD19 CAR T cell Production for Treatment of Patients with Chronic Lymphocytic Leukemia." Molecular Therapy. Methods & Clinical Development, vol. 32, no. 1, 2024, p. 101212, https://doi.org/10.1016/j.omtm.2024.101212.